We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Warning Letter to Sun Pharmaceuticals Takes FDA Requests to the Next Level
Warning Letter to Sun Pharmaceuticals Takes FDA Requests to the Next Level
The FDA is asking India-based Sun Pharmaceuticals to conduct tests and turn over reams of paperwork in response to a warning letter alleging more than a dozen cGMP violations.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor